“…The excellent concentrations in tissues (27), extremely low comparative cost (24) and lack of severe microbial resistance (24) have led to a high level of use of gentamicin for these purposes. It has a typical half‐life of 2–3 h, distributes quickly, mainly into extracellular space with an apparent volume of distribution of 0·25 L/kg, and binds to a small extent to plasma proteins (25, 37). Its use, however, is often limited because of its narrow safety margin and its relatively high incidence of nephrotoxicity (24, 37, 38) and ototoxicity (24, 37, 39).…”